Sayed O. Aseem, M.D., Ph.D.

Sayed O. Aseem, M.D., Ph.D.Gastroenterologist/Hepatologist Dr. Sayed Obaidullah (Obi) Aseem joined the Division of Gastroenterology, Hepatology and Nutrition in the Department of Internal Medicine and the Stravitz-Sanyal Liver Institute for Liver Disease and Metabolic Health faculties in 2022. He is a graduate of the NIH-sponsored Medical Scientist Training Program (M.D./Ph.D. training program) at the Medical University of South Carolina. Dr. Aseem completed his post-graduate training, residency in internal medicine and consecutive fellowships in gastroenterology and transplant hepatology, at the Mayo Clinic in Rochester, Minn. His clinical and research interests focus on cholestatic liver diseases. He is conducting basic and translational research studies to understand the mechanisms of biliary fibrosis in cholestatic liver diseases such as primary sclerosing cholangitis. Specifically, he focuses on unraveling the epigenetic mechanisms and transcriptomic changes that regulate the interactions between different liver cells that ultimately lead to fibrosis. He has published his work in top-tier journals such as Gastroenterology.

Department: Department of Internal Medicine

Dr. Sayed Obaidullah (Obi) Aseem joined the Division of Gastroenterology, Hepatology and Nutrition in the Department of Internal Medicine and the Stravitz-Sanyal Liver Institute for Liver Disease and Metabolic Health faculties in 2022. He is a graduate of the NIH-sponsored Medical Scientist Training Program (M.D./Ph.D. training program) at the Medical University of South Carolina. Dr. Aseem completed his post-graduate training, residency in internal medicine and consecutive fellowships in gastroenterology and transplant hepatology, at the Mayo Clinic in Rochester, Minn. His clinical and research interests focus on cholestatic liver diseases. He is conducting basic and translational research studies to understand the mechanisms of biliary fibrosis in cholestatic liver diseases such as primary sclerosing cholangitis. Specifically, he focuses on unraveling the epigenetic mechanisms and transcriptomic changes that regulate the interactions between different liver cells that ultimately lead to fibrosis. He has published his work in top-tier journals such as Gastroenterology. View his publications on PubMed.

Back to Listing